Insulin, Regular, Human: all 121 studies that test it
Page 1 of 2. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Peripheral Vascular Effects of Insulin in ObesityNot yet recruitingNCT07874945Early Phase 1
- Intranasal Insulin for Postoperative Delirium in Older Patients With T2DMNot yet recruitingNCT07720479Not applicable
- Interplay of Central and Peripheral Vascular Effects of Insulin in ObesityNot yet recruitingNCT07653464Early Phase 1
- INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesRecruitingNCT07224321Phase 2
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingNCT06558422Phase 1
- Dose Response Study of Transdermal Human Insulin in PatientsNot yet recruitingNCT05159453Phase 2/3
- Brain Insulin Resistance in Mood DisordersRecruitingNCT03915613Phase 1/2
- Topical Insulin for Ocular Surface Interface in Dry Eye DiseaseCompletedNCT06939959Phase 4Results posted
- Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 DiabetesCompletedNCT05243628Phase 4Results posted
- Transdermal Insulin Response In Healthy VolunteersCompletedNCT04857320Early Phase 1Results posted
- IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only PhaseTerminatedNCT04028960Phase 2Results posted
- Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes PatientsCompletedNCT03324776Phase 3Results posted
- Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT StudyCompletedNCT03143816Phase 4Results posted
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusCompletedNCT02561078Phase 3Results posted
- Afrezza Safety and Pharmacokinetics Study in Pediatric PatientsCompletedNCT02527265Phase 2Results posted
- Memory Aid by Intranasal Insulin in Diabetes (MemAID)CompletedNCT02415556Phase 2Results posted
- Study of Human Regular U-500 Insulin in Adult Participants With Type 2 DiabetesCompletedNCT01774968Phase 4Results posted
- Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusCompletedNCT01451398Phase 3Results posted
- Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT00916357Phase 2Results posted
- Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro AloneCompletedNCT00862849Phase 1Results posted
- Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes MellitusCompletedNCT00774800Phase 2Results posted
- Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20CompletedNCT00705536Phase 1Results posted
- Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-WeeksTerminatedNCT00700622Phase 3Results posted
- A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin LisproCompletedNCT00662857Phase 2Results posted
- Effect of Single Dose Intranasal Insulin On Cognitive FunctionCompletedNCT00646581Phase 4Results posted
- Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseTerminatedNCT00642616Phase 3Results posted
- A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 DiabetesCompletedNCT00570687Phase 2Results posted
- Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 DiabetesCompletedNCT00332488Phase 3Results posted
- Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-upCompletedNCT00309244Phase 3Results posted
- Safety of Inhaled Insulin With Type 1 and Type 2 DiabetesCompletedNCT00308737Phase 3Results posted
- Efficacy & Safety of Inhaled Insulin in Type 1 DiabetesCompletedNCT00308308Phase 3Results posted
- The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET StudyCompletedNCT00264641Not applicableResults posted
- Insulin Intratympanic ApplicationCompletedNCT07535827Early Phase 1
- Effect of Topical Insulin on Healing Rate of Pemphigus LesionsCompletedNCT07461103Phase 2
- INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 DiabetesCompletedNCT05904743Phase 4
- Pancreatic Clamp in NAFLDCompletedNCT05724134Phase 1
- Impact of Intranasal Insulin on Sympathetic Activity and Cerebral VasodilationSuspendedNCT05153395Early Phase 1
- Afrezza® INHALE-1 Study in PediatricsCompletedNCT04974528Phase 3
- Intraoperative Insulin Administration at Cardiac Surgery for Diabetic PatientsCompletedNCT04824586Phase 4
- Food Intake and Intra-Nasal Insulin for African American Adults (FIINAAL)CompletedNCT04739371Phase 1
- A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily InjectionsStatus unknownNCT04125082Phase 4
- Dose Response of Dance 501 in Subjects With Type 2 Diabetes MellitusCompletedNCT04100473Phase 2
- Pupillography as Screening Tool for Brain Insulin ResistanceCompletedNCT03651661Not applicable
- Effect of Intranasal Insulin on POCD and PODStatus unknownNCT03415061Not applicable
- PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPDTerminatedNCT03307512Phase 2
- A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 DiabetesCompletedNCT03102801Not applicable
- Effects of Intranasal Insulin Administration on Tissue Specific Insulin SensitivityCompletedNCT02933645Not applicable
- HbA1c Variability in Type II DiabetesActive, not recruitingNCT02879409Not applicable
- Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood GlucoseStatus unknownNCT02729064Phase 1
- Primary Intervention With Mucosal InsulinCompletedNCT02620553Phase 1/2
- PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)CompletedNCT02485327Phase 1
- Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight HumansCompletedNCT02468999Not applicable
- Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal MuscleCompletedNCT02370745Not applicable
- The Effects of Hypoglycaemia in People With Type 2 DiabetesCompletedNCT02205996Not applicable
- Neural Mechanism of Aldosterone-induced Insulin ResistanceWithdrawnNCT02102243Phase 4
- Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a HypoglycaemiaCompletedNCT02028078Phase 2
- Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin ApplicationCompletedNCT01797601Not applicable
- Insulin Therapy for Post-transplant Glucocorticoid Induced HyperglycemiaTerminatedNCT01648218Phase 4
- Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 DiabetesCompletedNCT01630369Phase 4
- The Effect of Insulin on Protein Metabolism After Cardiac SurgeryStatus unknownNCT01601561Not applicable
- Molecular Regulation of Muscle Glucose MetabolismTerminatedNCT01581736Phase 1
- Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 DiabetesCompletedNCT01544881Phase 1
- Establishing Cardiovascular Biomarkers to Define Preferred Lantus® UseStatus unknownNCT01500850Phase 4
- Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy VolunteersCompletedNCT01448070Phase 1
- Pharmacokinetic Study in Healthy VolunteersCompletedNCT01365117Phase 1
- Glucose Control in Severely Burned PatientsCompletedNCT01307306Not applicable
- Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 DiabetesCompletedNCT01269606Phase 1
- Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin ResistanceCompletedNCT01240252Phase 1
- Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 DiabetesCompletedNCT01194882Phase 3
- Investigating the Accuracy of the Home Glucose Monitors in HypoglycemiaCompletedNCT01013402Phase 4
- A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin LisproCompletedNCT01000922Phase 2
- Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 DiabetesCompletedNCT00934414Phase 2
- An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes MellitusCompletedNCT00875459Phase 3
- An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes MellitusCompletedNCT00875108Phase 3
- Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20CompletedNCT00803972Phase 1
- Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 DiabetesCompletedNCT00725036Phase 3
- Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesCompletedNCT00676819Phase 4
- Severe Insulin Resistance in Patients With Type 2 DiabetesCompletedNCT00654056Not applicable
- The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT00653510Not applicable
- Insulin Sensitivity of the Brain in Pathogenesis of Diabetes Mellitus Type 2Status unknownNCT00638209Not applicable
- Treatment of Impaired Glucose Tolerance in PregnancyCompletedNCT00625781Not applicable
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 DiabetesCompletedNCT00617565Phase 3
- Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesCompletedNCT00569400Phase 3
- Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 DiabetesCompletedNCT00567775Phase 2
- An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes MellitusCompletedNCT00542724Phase 3
- An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes MellitusCompletedNCT00542633Phase 3
- Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes MellitusCompletedNCT00539890Phase 3
- A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin GlargineCompletedNCT00539396Phase 2
- Evaluating Pharmacokinetics and Pharmacodynamics of JuslineCompletedNCT00532766Not applicable
- Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and AsthmaTerminatedNCT00523042Phase 3
- Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human InsulinCompletedNCT00511979Phase 1
- 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 DiabetesCompletedNCT00511732Phase 2
- Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 DiabetesCompletedNCT00511719Phase 2
- Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 DiabetesCompletedNCT00511602Phase 2
- Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and EfficacyStatus unknownNCT00505505Phase 4
- A Study for Patients With Type 2 Diabetes MellitusCompletedNCT00490854Phase 2/3
- Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.CompletedNCT00476437Phase 3
- Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00472953Phase 3
- Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 DiabetesTerminatedNCT00469586Phase 3
- Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00427154Phase 3